Β3-Adrenoceptor function and long-term changes in body weight

International Journal of Obesity

Volumn 33, Issue 6, 2009, Pages 662-668

  Andersson, D ^a   Wahrenberg, H ^a   Lofgren P ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CGP 12177; Dobutamine; Fat cells; Lipolysis; Terbutaline

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR;

ADIPOCYTE; ARTICLE; BIOASSAY; BODY MASS; BODY WEIGHT; ENERGY METABOLISM; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPOLYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SUBCUTANEOUS FAT; WEIGHT CHANGE; ADIPOSE TISSUE; ADULT; METABOLISM; PHYSIOLOGY; PROSPECTIVE STUDY;

ADIPOSE TISSUE; ADULT; BODY MASS INDEX; BODY WEIGHT; ENERGY METABOLISM; FEMALE; HUMANS; LIPOLYSIS; PROSPECTIVE STUDIES; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3;

EID: 67449110719     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.54     Document Type: Article

References (40)

1. James WP. The epidemiology of obesity: the size of the problem. J Intern Med 2008; 263: 336-352.
2. He XZ, Baker DW. Changes in weight among a nationally representative cohort of adults aged 51-61, 1992-2000. Am J Prev Med 2004; 27: 8-15.
3. Stubbs CO, Lee AJ. The obesity epidemic: both energy intake and physical activity contribute. Med J Aust 2004; 181: 489-491.
4. Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Thériault G et al. The response to long-term overfeeding in identical twins. N Engl J Med 1990; 322: 1477-1482.
5. Calhoun DA, Grass! G. Weight gain and hypertension: the chicken-egg question revisited. J Hypertens 2004; 22: 1869-1871.
6. Ravussin E, Gautier JF. Metabolic predictors of weight gain. Int J Obes Relat Metab Disord 1999; 23 (Suppl 1): 37-41.
7. Pischon T, Sharma AM. Use of beta-blockers in obesity hypertension: potential role of weight gain. Obes Rev 2001; 2: 275-280.
8. Clement K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352-354.
9. Strazzullo P, Iacone R, Siani A, Cappuccio FP, Russo O, Barba G et al. Relationship of the Trp64Arg polymorphism of the beta3adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens2001; 19: 399-406.
10. van Rossum CT, Hoebee B, Seidell JC, Bouchard C, van Baak MA, de Groot CP et al. Genetic factors as predictors of weight gain in young adult Dutch men and women. Int J Obes Relat Metab Disord 2002; 26: 517-528.
11. Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Elkasabany A, Gustat J et al. Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2002; 26: 928-937.
12. Koda M, Ando F, Niino N, Shimokata H, Miyasaka K, Funakoshi A. Association of cholecystokinin 1 receptor and beta3-adrenergic receptor polymorphisms with midlife weight gain. Obes Res 2004; 12: 1212-1216.
13. Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS. Interactive effects between polymorphisms in the beta-adrenergic receptors and longitudinal changes in obesity. Obes Res 2005; 13: 519-526.
14. Linne Y, Dahlman I, Hoffstedt J. betal-Adrenoceptor gene polymorphism predicts long-term changes in body weight. Int J Obes (Lond) 2005; 29: 458-462.
15. Collins S, Cao W, Robidoux J. Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism. Mol Endocrinol 2004; 18: 2123-2131.
16. Hellstrom L, Rossner S, Hagstrom-Toft E, Reynisdottir S. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity-a metabolic predictor of weight loss in obese subjects. Int J Obes Relat Metab Disord 1997; 21: 314-320.
17. Reynisdottir S, Wahrenberg H, Carlstrom K, Rossner S, Amer P. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors. Diabetologia 1994; 37: 428-435.
18. Amer P, Amer O, Ostman J. The effect of local anaesthetic agents on lipolysis by human adipose tissue. Life Sci 1973; 13: 161-169.
19. Lonnqvist F, Krief S, Strosberg AD, Nyberg S, Emorine LJ, Amer P. Evidence for a functional beta 3-adrenoceptor in man. Br J Pharmacol 1993; 110: 929-936.
20. Shimizu M, Blaak EE, Lonnqvist F, Gafvels ME, Amer P. Agonist and antagonist properties of beta 3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes. Pharmacol Toxicol 1996; 78: 254-263.
21. Sennitt MV, Kaumann AJ, Molenaar P, Beeley LJ, Young PW, Kelly J et al. The contribution of classical (betal/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3adrenoceptor agonists of differing selectivities. J Pharmacol Exp Ther1998; 285: 1084-1095.
22. Hoffstedt J, Naslund E, Amer P. Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells. J Clin Endocrinol Metab2002; 87: 3362-3367.
23. Amer P, Hellmer J, Wennlund A, Ostman J, Engfeldt P. Adrenoceptor occupancy in isolated human fat cells and its relationship with lipolysis rate. Eur J Pharmacol 1988; 146: 45-56.
24. Kenakin T. Drugs and receptors. An overview of the current state of knowledge. Drugs 1990; 40: 666-687.
25. Engfeldt P, Amer P, Ostman J. Influence of adipocyte isolation by collagenase on phosphodiesterase activity and lipolysis in man. J Lipid Res 1980; 21: 443-448.
26. Hoffstedt J, Poirier O, Thome A, Lönnqvist F, Herrmann SM, Cambien F et al. Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 1999; 48: 203-205.
27. Arch JR, Ainsworth AT, Cawthome MA, Piercy V, Sennitt MV, Thody VE et al. Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 1984; 309: 163-165.
28. Sundquist K, Qvist J, Johansson SE, Sundquist J. Increasing trends of obesity in Sweden between 1996/97 and 2000/01. Int J Obes Relat Metab Disord 2004; 28: 254-261.
29. Hellmer J, Wahrenberg H, Amer P. Stability over time of adrenergic sensitivity in isolated human fat cells. Int J Obes Relat Metab Disord 1992; 16: 23-28.
30. Enocksson S, Shimizu M, Lonnqvist F, Nordenstrom J, Amer P. Demonstration of an in vivo functional beta 3-adrenoceptor in man. J Clin Invest 1995; 95: 2239-2245.
31. Krief S, Lonnqvist F, Raimbault S, Baude B, Van Spronsen A, Amer P et al. Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest1993; 91: 344-349.
32. Weyer C, Tataranni PA, Snitker S, Danforth Jr E, Ravussin E. Increase in insulin action and fat oxidation after treatment with CL316,243, a highly selective beta3-adrenoceptor agonist in humans.. Diabetes 1998; 47: 1555-1561.
33. Kuczmarski R, Flegal K, Campbell S, Johnson S. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys 1960 to 1991. JAMA 1994; 272: 205-211.
34. Spalding KL, Amer E, Westermark PO, Bernard S, Buchholz BA, Bergmann O et al. Dynamics of fat cell turnover in humans. Nature 2008; 453: 783-787.
35. Hollenga C, Brouwer F, Zaagsma J. Differences in functional cyclic AMP compartments mediating lipolysis by isoprenaline and BRL 37344 in four adipocyte types. Eur J Pharmacol 1991; 6: 325-330.
36. Tavemier G, Barbe P, Galitzky J, Berlan M, Caput D, Lafontan M et al. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. / Lipid Res 1996; 37: 87-97.
37. Rosenbaum M, Malbon CC, Hirsch J, Leibel RL. Lack of beta 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. / Clin Endocrinol Metab 1993; 77: 352-355.
38. Hoffstedt J, Shimizu M, Sjöstedt S, Lonnqvist F. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells. Obes Res 1995;3:447-457.
39. McConnaughey MM, Sheets KA, Davis J, Privette J, Hickner R, Christian B et al. Differences in beta-adrenergic receptor densities in omental and subcutaneous adipose tissue from obese African American and Caucasian women. Metabolism 2004; 53: 247-251.
40. Woods SC, Gotoh K, Clegg DJ. Gender differences in the control of energy homeostasis. Exp Biol Med 2003; 228: 1175-1180.